 Keith Neeves
Concepts (367)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 29 | 2025 | 382 | 5.340 |
Why?
| | Blood Coagulation | 21 | 2024 | 239 | 4.270 |
Why?
| | Microfluidic Analytical Techniques | 19 | 2018 | 72 | 3.910 |
Why?
| | Thrombosis | 21 | 2024 | 348 | 3.870 |
Why?
| | Fibrin | 10 | 2024 | 68 | 2.510 |
Why?
| | Hemostasis | 8 | 2021 | 80 | 2.230 |
Why?
| | Hemophilia A | 5 | 2024 | 115 | 2.080 |
Why?
| | Platelet Aggregation | 14 | 2022 | 96 | 1.970 |
Why?
| | Thrombin | 6 | 2024 | 145 | 1.650 |
Why?
| | Platelet Activation | 8 | 2025 | 91 | 1.520 |
Why?
| | Colloids | 4 | 2020 | 57 | 1.410 |
Why?
| | Fibrinolysis | 4 | 2021 | 137 | 1.410 |
Why?
| | Drug Delivery Systems | 6 | 2022 | 333 | 1.320 |
Why?
| | Microfluidics | 10 | 2020 | 52 | 1.250 |
Why?
| | Tissue Plasminogen Activator | 3 | 2024 | 222 | 1.200 |
Why?
| | Platelet Adhesiveness | 6 | 2019 | 14 | 1.100 |
Why?
| | Vascular System Injuries | 3 | 2017 | 73 | 1.010 |
Why?
| | Factor VIIa | 2 | 2024 | 39 | 1.000 |
Why?
| | Lab-On-A-Chip Devices | 5 | 2021 | 36 | 0.980 |
Why?
| | Collagen | 9 | 2019 | 435 | 0.940 |
Why?
| | Blood Platelet Disorders | 2 | 2023 | 10 | 0.900 |
Why?
| | Magnetic Fields | 5 | 2022 | 22 | 0.860 |
Why?
| | Biomimetics | 2 | 2014 | 42 | 0.840 |
Why?
| | Nanoparticles | 4 | 2019 | 375 | 0.820 |
Why?
| | von Willebrand Factor | 5 | 2019 | 71 | 0.820 |
Why?
| | Plasminogen | 2 | 2024 | 31 | 0.810 |
Why?
| | Erythrocytes | 3 | 2018 | 673 | 0.740 |
Why?
| | Platelet Membrane Glycoproteins | 3 | 2018 | 35 | 0.690 |
Why?
| | Nanomedicine | 2 | 2022 | 32 | 0.680 |
Why?
| | Rheology | 3 | 2016 | 90 | 0.670 |
Why?
| | Thromboplastin | 7 | 2018 | 70 | 0.660 |
Why?
| | Plasminogen Activators | 1 | 2019 | 7 | 0.660 |
Why?
| | Thrombolytic Therapy | 2 | 2024 | 137 | 0.650 |
Why?
| | Fibrinolysin | 1 | 2019 | 17 | 0.650 |
Why?
| | Models, Biological | 7 | 2020 | 1724 | 0.650 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 90 | 0.640 |
Why?
| | Tranexamic Acid | 1 | 2019 | 37 | 0.620 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 47 | 0.620 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 757 | 0.620 |
Why?
| | Drug Carriers | 1 | 2019 | 119 | 0.600 |
Why?
| | Venous Valves | 1 | 2018 | 1 | 0.590 |
Why?
| | Cesium | 1 | 2018 | 20 | 0.590 |
Why?
| | Regional Blood Flow | 4 | 2017 | 463 | 0.590 |
Why?
| | Fibrinogen | 3 | 2017 | 163 | 0.550 |
Why?
| | Torpor | 1 | 2017 | 14 | 0.540 |
Why?
| | Genetic Diseases, Inborn | 1 | 2017 | 38 | 0.540 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 262 | 0.540 |
Why?
| | Factor VIII | 4 | 2024 | 87 | 0.520 |
Why?
| | Hemorrhage | 2 | 2019 | 680 | 0.520 |
Why?
| | Venous Thrombosis | 1 | 2018 | 177 | 0.500 |
Why?
| | Pharmaceutical Preparations | 3 | 2021 | 171 | 0.500 |
Why?
| | Sciuridae | 1 | 2017 | 146 | 0.490 |
Why?
| | Heating | 1 | 2015 | 20 | 0.480 |
Why?
| | Humans | 53 | 2025 | 129625 | 0.470 |
Why?
| | Bleeding Time | 1 | 2015 | 7 | 0.470 |
Why?
| | Ferric Compounds | 1 | 2015 | 46 | 0.470 |
Why?
| | Water Pollutants, Chemical | 1 | 2018 | 196 | 0.470 |
Why?
| | Protein Aggregates | 1 | 2015 | 67 | 0.470 |
Why?
| | Saphenous Vein | 1 | 2015 | 32 | 0.460 |
Why?
| | Chlorides | 1 | 2015 | 139 | 0.460 |
Why?
| | Cell Adhesion | 3 | 2014 | 452 | 0.450 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2018 | 22 | 0.450 |
Why?
| | Stress, Mechanical | 7 | 2018 | 467 | 0.440 |
Why?
| | Metabolic Flux Analysis | 2 | 2025 | 7 | 0.430 |
Why?
| | Epigastric Arteries | 1 | 2012 | 24 | 0.400 |
Why?
| | Polymers | 4 | 2015 | 477 | 0.400 |
Why?
| | Animals | 33 | 2024 | 35391 | 0.400 |
Why?
| | Femoral Vein | 1 | 2012 | 32 | 0.400 |
Why?
| | Collagen Type I | 1 | 2013 | 118 | 0.390 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 80 | 0.390 |
Why?
| | Extracellular Fluid | 2 | 2013 | 31 | 0.380 |
Why?
| | E-Selectin | 1 | 2012 | 55 | 0.380 |
Why?
| | Nanotubes | 1 | 2012 | 43 | 0.370 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2012 | 70 | 0.370 |
Why?
| | Carotid Arteries | 1 | 2012 | 196 | 0.360 |
Why?
| | Fibrin Clot Lysis Time | 2 | 2021 | 9 | 0.360 |
Why?
| | Cell Separation | 1 | 2012 | 317 | 0.350 |
Why?
| | Vascular Diseases | 1 | 2013 | 240 | 0.350 |
Why?
| | Factor V | 2 | 2020 | 18 | 0.340 |
Why?
| | Hemodynamics | 4 | 2018 | 1090 | 0.330 |
Why?
| | Endothelial Cells | 1 | 2015 | 749 | 0.330 |
Why?
| | Biophysics | 1 | 2010 | 68 | 0.330 |
Why?
| | Blood Flow Velocity | 4 | 2018 | 406 | 0.320 |
Why?
| | Groundwater | 2 | 2020 | 36 | 0.310 |
Why?
| | Receptors, Thrombin | 1 | 2008 | 12 | 0.310 |
Why?
| | Platelet Function Tests | 3 | 2021 | 25 | 0.290 |
Why?
| | Kinetics | 5 | 2018 | 1645 | 0.290 |
Why?
| | Adenosine Diphosphate | 1 | 2008 | 80 | 0.290 |
Why?
| | Membranes, Artificial | 1 | 2008 | 71 | 0.290 |
Why?
| | Pulmonary Embolism | 2 | 2022 | 212 | 0.290 |
Why?
| | Nitric Oxide | 1 | 2013 | 895 | 0.280 |
Why?
| | Porosity | 3 | 2020 | 92 | 0.280 |
Why?
| | Neostriatum | 1 | 2007 | 33 | 0.280 |
Why?
| | Dilatation | 1 | 2007 | 61 | 0.270 |
Why?
| | Computer Simulation | 3 | 2020 | 939 | 0.270 |
Why?
| | Biological Transport | 3 | 2017 | 404 | 0.240 |
Why?
| | Silicon Dioxide | 2 | 2018 | 109 | 0.240 |
Why?
| | Stroke | 2 | 2024 | 1071 | 0.240 |
Why?
| | Adventitia | 1 | 2025 | 43 | 0.230 |
Why?
| | Hydrodynamics | 5 | 2019 | 40 | 0.230 |
Why?
| | Equipment Design | 6 | 2016 | 514 | 0.230 |
Why?
| | Extracellular Matrix | 2 | 2011 | 506 | 0.230 |
Why?
| | Microscopy, Electron, Scanning | 3 | 2014 | 196 | 0.210 |
Why?
| | Lipoproteins | 1 | 2024 | 172 | 0.210 |
Why?
| | von Willebrand Diseases | 1 | 2023 | 24 | 0.200 |
Why?
| | Shear Strength | 4 | 2019 | 67 | 0.200 |
Why?
| | Gels | 2 | 2015 | 81 | 0.200 |
Why?
| | Estrogens | 1 | 2025 | 347 | 0.200 |
Why?
| | Leukocyte Elastase | 1 | 2022 | 77 | 0.190 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 67 | 0.190 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 191 | 0.180 |
Why?
| | Hematocrit | 2 | 2018 | 93 | 0.180 |
Why?
| | Recombinant Proteins | 1 | 2024 | 1308 | 0.180 |
Why?
| | Models, Theoretical | 3 | 2019 | 546 | 0.180 |
Why?
| | Respiratory Mucosa | 2 | 2014 | 310 | 0.170 |
Why?
| | Fibroblasts | 1 | 2025 | 953 | 0.170 |
Why?
| | High-Energy Shock Waves | 1 | 2019 | 4 | 0.160 |
Why?
| | Blood Coagulation Tests | 2 | 2021 | 60 | 0.160 |
Why?
| | ADAMTS13 Protein | 1 | 2019 | 6 | 0.160 |
Why?
| | Magnetite Nanoparticles | 1 | 2019 | 29 | 0.160 |
Why?
| | Semaphorins | 2 | 2010 | 28 | 0.160 |
Why?
| | Mice | 13 | 2022 | 16961 | 0.160 |
Why?
| | Convection | 3 | 2011 | 6 | 0.160 |
Why?
| | Drug Compounding | 1 | 2019 | 97 | 0.160 |
Why?
| | Herpes Zoster | 1 | 2023 | 317 | 0.160 |
Why?
| | Male | 19 | 2025 | 63670 | 0.160 |
Why?
| | Pulmonary Artery | 1 | 2025 | 1097 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2024 | 3378 | 0.150 |
Why?
| | Microelectrodes | 3 | 2007 | 42 | 0.150 |
Why?
| | Liposomes | 1 | 2019 | 171 | 0.150 |
Why?
| | Geologic Sediments | 1 | 2018 | 39 | 0.150 |
Why?
| | von Willebrand Disease, Type 1 | 1 | 2017 | 2 | 0.150 |
Why?
| | Robotics | 1 | 2019 | 93 | 0.140 |
Why?
| | Hemorheology | 1 | 2017 | 21 | 0.140 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 44 | 0.140 |
Why?
| | Phosphatidylserines | 1 | 2018 | 88 | 0.140 |
Why?
| | Viscosity | 2 | 2015 | 90 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1366 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 183 | 0.140 |
Why?
| | Antithrombin III | 1 | 2017 | 8 | 0.140 |
Why?
| | Magnetics | 1 | 2017 | 43 | 0.140 |
Why?
| | Thromboxane A2 | 1 | 2016 | 11 | 0.140 |
Why?
| | Antigens, CD | 2 | 2010 | 487 | 0.140 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2016 | 6 | 0.140 |
Why?
| | Flow Cytometry | 3 | 2016 | 1159 | 0.140 |
Why?
| | Adsorption | 2 | 2020 | 139 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2025 | 4084 | 0.130 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2018 | 443 | 0.130 |
Why?
| | Peptide Hydrolases | 1 | 2017 | 108 | 0.130 |
Why?
| | Blood Cells | 1 | 2015 | 39 | 0.120 |
Why?
| | Models, Molecular | 1 | 2021 | 1491 | 0.120 |
Why?
| | Adenine | 1 | 2018 | 258 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 87 | 0.120 |
Why?
| | Piperazines | 1 | 2018 | 340 | 0.120 |
Why?
| | Clot Retraction | 1 | 2015 | 2 | 0.120 |
Why?
| | Time Factors | 4 | 2017 | 6555 | 0.120 |
Why?
| | Electrodes | 1 | 2015 | 105 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 265 | 0.120 |
Why?
| | Pneumonia | 1 | 2020 | 617 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2015 | 122 | 0.110 |
Why?
| | Bioreactors | 1 | 2014 | 42 | 0.110 |
Why?
| | Blood Vessels | 1 | 2016 | 187 | 0.110 |
Why?
| | Toxicity Tests | 1 | 2014 | 29 | 0.110 |
Why?
| | Enzyme Precursors | 1 | 2014 | 14 | 0.110 |
Why?
| | Nanotechnology | 2 | 2013 | 121 | 0.110 |
Why?
| | Signal Transduction | 4 | 2018 | 4931 | 0.110 |
Why?
| | Temperature | 1 | 2017 | 637 | 0.110 |
Why?
| | Rats | 5 | 2014 | 5483 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 307 | 0.110 |
Why?
| | Cysteine Endopeptidases | 1 | 2013 | 68 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2395 | 0.110 |
Why?
| | Bronchi | 2 | 2012 | 249 | 0.110 |
Why?
| | Hypoxia | 1 | 2020 | 1084 | 0.110 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2014 | 82 | 0.100 |
Why?
| | Models, Chemical | 1 | 2015 | 263 | 0.100 |
Why?
| | Azo Compounds | 1 | 2013 | 26 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 175 | 0.100 |
Why?
| | Optical Tweezers | 1 | 2013 | 21 | 0.100 |
Why?
| | Materials Testing | 1 | 2015 | 342 | 0.100 |
Why?
| | Surface Properties | 2 | 2019 | 397 | 0.100 |
Why?
| | Lipid Bilayers | 1 | 2014 | 97 | 0.100 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 6 | 0.100 |
Why?
| | Factor VII | 1 | 2012 | 22 | 0.100 |
Why?
| | Permeability | 1 | 2013 | 157 | 0.100 |
Why?
| | Fibrillar Collagens | 1 | 2012 | 14 | 0.100 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 21 | 0.100 |
Why?
| | Horses | 1 | 2013 | 107 | 0.100 |
Why?
| | Biomechanical Phenomena | 2 | 2013 | 764 | 0.100 |
Why?
| | Polymerization | 1 | 2013 | 123 | 0.100 |
Why?
| | Spectrophotometry | 1 | 2012 | 57 | 0.100 |
Why?
| | Microvilli | 1 | 2012 | 79 | 0.100 |
Why?
| | Linear Models | 1 | 2015 | 819 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 399 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2020 | 4078 | 0.100 |
Why?
| | Observer Variation | 1 | 2013 | 314 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 338 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 887 | 0.090 |
Why?
| | Polystyrenes | 2 | 2011 | 37 | 0.090 |
Why?
| | Female | 11 | 2025 | 68734 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2013 | 167 | 0.090 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 66 | 0.090 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 89 | 0.090 |
Why?
| | Microscopy, Atomic Force | 1 | 2011 | 118 | 0.090 |
Why?
| | Protein Binding | 2 | 2020 | 2124 | 0.090 |
Why?
| | Cell Membrane | 2 | 2015 | 734 | 0.090 |
Why?
| | Lung | 2 | 2020 | 3938 | 0.090 |
Why?
| | Ozone | 1 | 2011 | 103 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 419 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2014 | 1075 | 0.090 |
Why?
| | Platelet Factor 4 | 2 | 2020 | 34 | 0.090 |
Why?
| | Integrins | 1 | 2010 | 94 | 0.080 |
Why?
| | Societies, Medical | 1 | 2014 | 744 | 0.080 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 499 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 740 | 0.080 |
Why?
| | Absorbable Implants | 1 | 2009 | 35 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 136 | 0.080 |
Why?
| | src-Family Kinases | 1 | 2009 | 95 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2016 | 3080 | 0.080 |
Why?
| | Integrin alpha2beta1 | 1 | 2008 | 3 | 0.080 |
Why?
| | Dimethylpolysiloxanes | 1 | 2008 | 9 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1894 | 0.070 |
Why?
| | Hyperlipidemias | 1 | 2009 | 126 | 0.070 |
Why?
| | Silicones | 1 | 2008 | 22 | 0.070 |
Why?
| | Water | 1 | 2011 | 441 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 439 | 0.070 |
Why?
| | Cell Membrane Permeability | 1 | 2008 | 82 | 0.070 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2007 | 8 | 0.070 |
Why?
| | Protein Array Analysis | 1 | 2008 | 56 | 0.070 |
Why?
| | Electrodes, Implanted | 2 | 2006 | 106 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 441 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2007 | 166 | 0.070 |
Why?
| | Molecular Weight | 1 | 2007 | 329 | 0.070 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 431 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 315 | 0.070 |
Why?
| | Algorithms | 2 | 2011 | 1616 | 0.060 |
Why?
| | Reference Values | 1 | 2008 | 794 | 0.060 |
Why?
| | Insecta | 1 | 2006 | 64 | 0.060 |
Why?
| | Evans Blue | 1 | 2006 | 7 | 0.060 |
Why?
| | Caudate Nucleus | 1 | 2006 | 20 | 0.060 |
Why?
| | Diffusion | 1 | 2006 | 116 | 0.060 |
Why?
| | Extremities | 1 | 2006 | 127 | 0.060 |
Why?
| | Albumins | 1 | 2006 | 103 | 0.060 |
Why?
| | Muscles | 1 | 2006 | 320 | 0.060 |
Why?
| | Phenotype | 1 | 2013 | 3075 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 399 | 0.060 |
Why?
| | Brain | 2 | 2009 | 2673 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 402 | 0.060 |
Why?
| | Infusion Pumps, Implantable | 1 | 2004 | 22 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2004 | 28 | 0.060 |
Why?
| | Movement | 2 | 2017 | 270 | 0.060 |
Why?
| | Anticoagulants | 2 | 2021 | 637 | 0.050 |
Why?
| | Immunoblotting | 2 | 2016 | 305 | 0.050 |
Why?
| | Elasticity | 2 | 2015 | 195 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1843 | 0.050 |
Why?
| | Child, Preschool | 2 | 2017 | 10490 | 0.050 |
Why?
| | Electric Impedance | 2 | 2014 | 102 | 0.050 |
Why?
| | P-Selectin | 1 | 2022 | 27 | 0.050 |
Why?
| | CD36 Antigens | 1 | 2022 | 36 | 0.050 |
Why?
| | Apolipoprotein A-I | 1 | 2022 | 28 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 275 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2022 | 115 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 97 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 51 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2011 | 1066 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2010 | 1145 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2021 | 35 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2016 | 2881 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 205 | 0.050 |
Why?
| | Young Adult | 2 | 2017 | 12455 | 0.050 |
Why?
| | Blood Pressure | 1 | 2008 | 1736 | 0.040 |
Why?
| | Chemokine CCL5 | 1 | 2020 | 43 | 0.040 |
Why?
| | Factor Xa | 1 | 2020 | 32 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5455 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2020 | 206 | 0.040 |
Why?
| | Carbon | 1 | 2021 | 204 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 109 | 0.040 |
Why?
| | Phosphorylation | 2 | 2018 | 1713 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 147 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2020 | 20 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2025 | 736 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 432 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 315 | 0.040 |
Why?
| | Research | 1 | 2023 | 419 | 0.040 |
Why?
| | Zebrafish | 1 | 2024 | 460 | 0.040 |
Why?
| | Herpesvirus 3, Human | 1 | 2023 | 331 | 0.040 |
Why?
| | Catheterization | 2 | 2010 | 175 | 0.040 |
Why?
| | Rotation | 1 | 2019 | 112 | 0.040 |
Why?
| | Motion | 1 | 2019 | 98 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2020 | 186 | 0.040 |
Why?
| | Adolescent | 2 | 2017 | 20412 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 243 | 0.040 |
Why?
| | Adult | 3 | 2019 | 35599 | 0.040 |
Why?
| | Hydrogels | 1 | 2025 | 630 | 0.040 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2017 | 11 | 0.040 |
Why?
| | Uncertainty | 1 | 2018 | 121 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 318 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2020 | 835 | 0.030 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2018 | 66 | 0.030 |
Why?
| | Hemostatics | 1 | 2017 | 50 | 0.030 |
Why?
| | Drug Synergism | 1 | 2018 | 370 | 0.030 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 78 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1210 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 374 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2018 | 231 | 0.030 |
Why?
| | Machine Learning | 1 | 2020 | 443 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 636 | 0.030 |
Why?
| | Miniaturization | 1 | 2015 | 23 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 41 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2014 | 8 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 100 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1042 | 0.030 |
Why?
| | Megakaryocytes | 1 | 2014 | 32 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 636 | 0.030 |
Why?
| | Platelet Transfusion | 1 | 2014 | 59 | 0.030 |
Why?
| | Chlorine | 1 | 2014 | 59 | 0.030 |
Why?
| | Biomimetic Materials | 1 | 2014 | 69 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2015 | 215 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3262 | 0.030 |
Why?
| | Inhalation Exposure | 1 | 2014 | 91 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1432 | 0.030 |
Why?
| | Erythrocyte Deformability | 1 | 2013 | 15 | 0.030 |
Why?
| | Gases | 1 | 2013 | 44 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2014 | 667 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1947 | 0.020 |
Why?
| | Pressure | 1 | 2013 | 237 | 0.020 |
Why?
| | Nitrogen | 1 | 2013 | 162 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 317 | 0.020 |
Why?
| | Serum Albumin, Bovine | 1 | 2011 | 63 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 354 | 0.020 |
Why?
| | Trachea | 1 | 2012 | 226 | 0.020 |
Why?
| | Microtechnology | 1 | 2010 | 7 | 0.020 |
Why?
| | Syk Kinase | 1 | 2010 | 21 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 29 | 0.020 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 217 | 0.020 |
Why?
| | Catheters | 1 | 2010 | 66 | 0.020 |
Why?
| | Particle Size | 1 | 2011 | 351 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 157 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 591 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 307 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2011 | 312 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2009 | 6 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2750 | 0.020 |
Why?
| | Diet, Atherogenic | 1 | 2009 | 6 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1076 | 0.020 |
Why?
| | Proline | 1 | 2009 | 76 | 0.020 |
Why?
| | Factor XIIa | 1 | 2008 | 2 | 0.020 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 3 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 316 | 0.020 |
Why?
| | Plant Proteins | 1 | 2008 | 89 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 31136 | 0.020 |
Why?
| | Amplifiers, Electronic | 1 | 2006 | 7 | 0.020 |
Why?
| | Cockroaches | 1 | 2006 | 20 | 0.020 |
Why?
| | Xylenes | 1 | 2006 | 7 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 263 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3968 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 210 | 0.020 |
Why?
| | Locomotion | 1 | 2006 | 100 | 0.020 |
Why?
| | Transferrin | 1 | 2004 | 42 | 0.010 |
Why?
| | Equipment Failure | 1 | 2004 | 106 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1212 | 0.010 |
Why?
| | Running | 1 | 2006 | 223 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 2021 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 10219 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2004 | 869 | 0.010 |
Why?
| | Aged | 1 | 2017 | 22061 | 0.010 |
Why?
| | Child | 1 | 2017 | 20884 | 0.010 |
Why?
|
|
Neeves's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|